A scientist works on developing the H1N1 vaccine inside a Bio-safety Level 3 lab at Sillapakorn University on the outskirts of Bangkok
A scientist works on developing the H1N1 (Influenza A) vaccine inside a Bio-safety Level 3 (BSL-3) lab at Sillapakorn University on the outskirts of Bangkok July 12, 2009. The vaccine is expected to be launched around October 2009 and the plant located at the university will be able to produce more than 2 million doses per month. REUTERS/Chaiwat Subprasom (THAILAND SOCIETY HEALTH POLITICS)
Content available for editorial use, pre-approval required for all other uses.
Content may not be substantially altered without pre-approval from provider.
May not credit Reuters for commercial, political, or advertising usage.
Not available for distribution, sale, or license by Corbis' international representatives.
Reuters content is available for license and invoicing to customers located in the United States, United Kingdom, Canada, Germany, and Belgium only.
Uncompressed file sizes and pixel dimensions are approximate. Grayscale images are 1/3 the file size of RGB files. Files downloaded directly from the website are compressed JPEG format. You may request a TIFF file, if available, or a larger interpolated size for your output needs. Please contact Customer Service for associated production fees.